Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05153265 · ClinicalTrials.gov registry record
The CIA Score: a Learner's Tool
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 69
- Enrollment target
NCT05153265: Completed study, sponsored by Stanford University.
NCT05153265 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 69 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05153265 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 69 participants
- Enrollment target
Study Summary
The goal of this project is to use a previously described scoring system - the CIA system - as a teaching tool to help learners assess the bleeding risk of peripheral nerve blocks. We will teach the CIA system to residents, then they will complete a survey in which they apply the system to various peripheral nerve blocks. We hypothesize that the CIA system will allow learners to reach the same consensus about bleeding risk as expert opinions.
Primary Outcome
The bleeding risk of each peripheral nerve block as assessed by trainees, using the CIA scoring system.
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2021-11-23 |
| Est. Completion | 2021-12-23 |
What the finished NCT05153265 record still lists
NCT05153265 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 69 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT05153265 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05153265 about?
NCT05153265 is a clinical study titled "The CIA Score: a Learner's Tool". The goal of this project is to use a previously described scoring system - the CIA system - as a teaching tool to help learners assess the bleeding risk of peripheral nerve blocks. We will teach the CIA system to residents, then they will complete a survey in which they apply the system to various p...
What is the current status of trial NCT05153265?
This trial is currently completed. The enrollment target is 69 participants. The study started on 2021-11-23. Estimated completion is 2021-12-23.
What interventions are being tested in trial NCT05153265?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT05153265?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI